The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Venous Thromboembolism Market During The Forecast Period 2026–2030?

The venous thromboembolism market size has experienced consistent growth in recent years. It is anticipated to increase from $2.53 billion in 2025 to $2.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 3.9%. In the past, this growth was primarily due to a rising incidence of venous thromboembolism, an aging population, the increasing prevalence of sedentary lifestyles, enhanced clinical awareness regarding VTE risks, and the expansion of hospital-based thrombotic care.

The venous thromboembolism market is projected to experience consistent expansion in the upcoming years. This market is anticipated to reach $3.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. This anticipated growth over the forecast period stems from factors such as the greater acceptance of personalized anticoagulant therapy, the escalating need for minimally invasive treatment alternatives, the broadening of outpatient VTE care frameworks, increased funding for sophisticated diagnostic instruments, and a heightened emphasis on preventive thrombosis management. Key trends identified for the forecast timeframe encompass the expanding utilization of novel oral anticoagulants, a surge in the application of mechanical thrombectomy devices, an intensified focus on prompt diagnosis and risk assessment, the development of home-based VTE management initiatives, and enhanced oversight of anticoagulant therapy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13001&type=smp

What Underlying Factors Are Accelerating The Growth Of The Venous Thromboembolism Market?

The expansion of healthcare infrastructure is projected to drive the growth of the venous thromboembolism market moving forward. The healthcare industry consolidates and integrates various economic sectors that provide products and services for patient treatment, prevention, rehabilitation, and palliative care. The development within this industry fosters institutional infrastructure, policies, practices, and educational programs essential for implementing VTE prevention protocols. For instance, the American Health Care Association, a US-based nonprofit, reported in May 2023 that the number of hospitals in the US rose to 6,129 from 6,093 in 2022. Hence, the expanding healthcare industry is a significant driver for the venous thromboembolism market’s growth.

What Market Segments Are Evaluated Within The Venous Thromboembolism Market?

The venous thromboembolism market covered in this report is segmented –

1) By Type: Deep Vein Thrombosis, Pulmonary Embolism, Other Types

2) By Treatment: Anti-Clotting Medications, Mechanical Devices, Thrombolytic Therapy, Other Treatment

3) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Deep Vein Thrombosis (DVT): Proximal DVT, Distal DVT, Asymptomatic DVT

2) By Pulmonary Embolism (PE): Acute PE, Chronic PE, Submassive PE

3) By Other Types: Thrombophlebitis, Superficial Vein Thrombosis, Post-Thrombotic Syndrome

How Are Trends Impacting The Venous Thromboembolism Market?

Leading companies operating within the venous thromboembolism (VTE) market are concentrating on integrating advanced vascular-access sheath technology, such as laser-cut hypotube sheaths, to elevate efficiency, safety, and procedural management. This laser-cut hypotube sheath technology utilizes a thin-walled metal tube precisely cut by laser, yielding a sheath that is both adaptable and structurally sound. This design facilitates capabilities like smooth navigation within blood vessels, dependable support during catheter delivery, and enhanced hemostasis control during procedures. For instance, in January 2025, Penumbra Inc., a US-based medical-device manufacturer, introduced the Element Vascular Access System, a laser-cut hypotube sheath developed specifically for venous thromboembolism procedures. It incorporates the HemoLock dual-valve system for precise hemostasis control, an atraumatic tip design, and 17 F MaxID sizing, ensuring smooth delivery and compatibility with large-bore thrombectomy catheters. The Element system improves procedure efficiency, device trackability, and physician control, which could significantly enhance safety and treatment outcomes in VTE interventions.

Who Are The Top Market Participants Influencing The Venous Thromboembolism Market?

Major companies operating in the venous thromboembolism market are Pfizer Inc., Johnson and Johnson Limited, Merck and Co Inc, AbbVie Inc, Bayer AG, Novartis AG, Sanofi-Aventis LLC, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly and Co Ltd, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Portola Pharmaceuticals Inc, Viatris Inc, AstraZeneca PLC, Medtronic plc, Boston Scientific Corporation, Stryker Corporation, Abbott Laboratories, AngioDynamics Inc, Terumo Corporation

Read the full venous thromboembolism market report here:

https://www.thebusinessresearchcompany.com/report/venous-thromboembolism-global-market-report

Which Region Is Projected To Dominate The Venous Thromboembolism Market During The Forecast Period?

North America was the largest region in the venous thromboembolism market in 2025. The regions covered in the venous thromboembolism market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Venous Thromboembolism Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13001&type=smp

Browse Through More Reports Similar to the Global Venous Thromboembolism Market 2026, By The Business Research Company

Deep Vein Thrombosis Global Market Report

https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report

Thrombophilia Global Market Report

https://www.thebusinessresearchcompany.com/report/thrombophilia-global-market-report

Vascular Embolization Global Market Report

https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.